The final agenda reflects as promised the meeting title with a focus on how medical information exchange and education programmes, through meetings can affect positive patient outcomes.
Central to the dialogue between stage and audience is an exciting survey of Healthcare Professionals (HCP’s), the critical link between scientific information and positive patient outcomes. The survey to be distributed by a number of Medical Societies including the European Society of Cardiology, focuses on their views on medical meetings; what is good content, who best provides this, how do they wish it delivered to them, with a part devoted to the results of the recent transparency directive, how does this affect them, what evidence can we gather as to the outcome of this critical initiative? This cutting edge data will provide evidence as to the nature of the evolving relationship between all parties critical in providing the very best patient care.
The survey results will be debated by a panel from the HCP, Medical Society and Industry communities, Alistair Lindsay a cardiologist at the Royal Brompton Hospital, London, and a serving member of the editorial board of the cardiovascular journal Heart will present and be part of the panel discussion who feels "Healthcare professionals, like many others, face multiple competing demands on our time. Understanding how medical meetings can evolve to efficiently deliver relevant education that has a direct bearing on patient outcomes, but in an efficient way, is extremely topical and relevant."
A hot topic will shine a light on the procurement of meeting services with Andrew Winterburn, Global Business Development Director at Ashfield Events. Central to this segment of the programme, Andrew will concentrate on how the specialist agency community has evolved their procurement strategies and feels “Agency strategies have moved on from the early 90’s with a developed understanding of the procurement process and how to gain win, win outcomes. However there are many challenges, is it realistic in the future to be asked to pay for pitches, we want to explore this and more at the Forum.” This session will be supported by speakers from corporate procurement and importantly a global venue group specialist in delivering a product to the healthcare sector.”
Industry perspectives on how the relationships between industry and Healthcare Professionals have evolved post the reality of financial transparency disclosure regulations will be delivered by Thomas Stark, Vice President EMEA Medical Affairs at Janssen who said “Janssen’s core ambition is to bring innovative treatments for unmet medical needs to patients and deliver great outcomes. An open co-operation between pharmaceutical companies and healthcare professionals is essential for achieving this. We are encouraging all of our healthcare professional partners to join us as we strive towards greater transparency.”
Davi Kaur, Head of the Congress Unit at the European Cancer Organisation will provide an insight into what optimal content at Medical congresses looks like, as a critical pillar in HCP education the medical congresses has evolved over particularly the last 5 years to be a sophisticated education and information tool, Davi is passionate in believing “we will put the focus onto the delivery of good science at medical meetings, there has been a revolution in the formats and delivery methodologies and this is often unrecognised. What does the congress audience of the future want to hear, see and be involved in to support positive patient outcomes? ”